Evidence map›Paper›PMID 28844958›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2017

Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.

Naoki Tanaka, Shogo Takahashi, Xiao Hu, Yu Lu, Naoyuki Fujimori, Srujana Golla, Zhong-Ze Fang, Toshifumi Aoyama, Kristopher W Krausz, Frank J Gonzalez

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TRIB3 Is a Hub Gene in Steatohepatitis and Aggravates Lipid Deposition and Inflammation in Hepatocytes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Gadd45 in Senescence.Advances in experimental medicine and biology · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Naoki TanakaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States; Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan; Research Center for Agricultural Food Industry, Shinshu University, Matsumoto, Japan.
Shogo TakahashiLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Xiao HuDepartment of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
Yu LuDepartment of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
Naoyuki FujimoriDepartment of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
Srujana GollaLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Zhong-Ze FangLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States; Department of Toxicology, School of Public Health, Tianjin Medical University, Tianjin, China.
Toshifumi AoyamaDepartment of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
Kristopher W KrauszLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Frank J GonzalezLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States. Electronic address: gonzalef@mail.nih.gov.
National Institutes of Health · USShinshu University · JP

Funding

Xenobiotic receptorsZIABC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$26.9M
MOUSE BIOMARKER DISCOVERY AND VALIDATION STUDIESU54ES016015 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI POUNDS, JOEL G · 2007 to 2010
$5.8M
TRANSCRIPTIONAL REGULATION OF GENES ENCODING XENOBIOTIC METABOLIZING ENZYMESZ01BC005561 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK · 1996 to 2008
$754k
Intramural NIH HHS Z01 BC005561NIEHS NIH HHS U54 ES016015
6 · The paper itself

Abstract

Growth arrest and DNA damage-inducible 45 α (Gadd45α) is a stress-inducible protein that plays an important role in cell survival/death and DNA repair, but its contribution to the development of nonalcoholic steatohepatitis (NASH) has not been investigated. C57BL/6 Gadd45a-null and wild-type (WT) mice were treated with a methionine and choline-deficient diet (MCD) for eight weeks and phenotypic changes examined. Gadd45a-null mice had more severe hepatic inflammation and fibrosis, higher levels of mRNAs encoding pro-inflammatory, pro-fibrotic, and pro-apoptotic proteins, and greater oxidative and endoplasmic reticulum (ER) stress compared with WT mice. Indeed, Gadd45a mRNA was induced in response to ER stress in primary hepatocytes. Lipidomic analysis of NASH livers demonstrated decreased triacylglycerol (TG) in MCD-treated Gadd45a-null mice, which was associated with increased mRNAs encoding phospholipase D (Pld1/2), phosphatidic acid phosphatase type 2A, and choline/ethanolamine phosphotransferase 1 (Cept1), involved in the phosphatidylcholine-phosphatidic acid-diacylglycerol cycle, and decreased mRNAs encoding fatty acid (FA)-binding protein 1 (Fabp1) and FA transport protein 5. Treatment of cultured primary hepatocytes with tumor necrosis factor α, transforming growth factor β, and hydrogen peroxide led to the corresponding induction of Fabp1, Pld1/2, and Cept1 mRNAs. Collectively, Gadd45α plays protective roles against MCD-induced NASH likely due to attenuating cellular stress and ensuing inflammatory signaling. These results also suggest an interconnection between hepatocyte injury, inflammation and disrupted glycerophospholipid/FA metabolism that yields a possible mechanism for decreased TG accumulation with NASH progression (i.e., "burned-out" NASH).

Indexed as

AnimalsCell Cycle ProteinsCholine DeficiencyDietEndoplasmic Reticulum StressFatty Acid-Binding ProteinsFatty AcidsFatty Acid Transport ProteinsGADD45 ProteinsGlycerophospholipidsHepatocytesMaleMethionineMice, Inbred C57BLMice, KnockoutNon-alcoholic Fatty Liver DiseaseCell Cycle Proteinscholine-ethanolaminephosphotransferaseFabp1 protein, mouseFatty Acid-Binding ProteinsFatty AcidsFatty Acid Transport ProteinsGadd45a protein, mouseGADD45 ProteinsGlycerophospholipidslipid phosphate phosphataseMethionineNuclear ProteinsPhosphatidate PhosphatasePhospholipase Dphospholipase D1phospholipase D2RNA, MessengerTransferases (Other Substituted Phosphate Groups)Transforming Growth Factor betaTriglyceridesTumor Necrosis Factor-alphaBurned-out NASHER stressGlycerophospholipid metabolismLipidomicsOxidative stress

Identifiers

PMID28844958
PMCPMC5675002
OpenAlexW2748231322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.